Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "board"

887 News Found

Microbot Medical expands LIBERTY Robotic System commercial rollout
Medical Device | May 05, 2026

Microbot Medical expands LIBERTY Robotic System commercial rollout

The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts


OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection
News | May 04, 2026

OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection

Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing


Health ministry releases new healthcare safety guidelines
Policy | May 04, 2026

Health ministry releases new healthcare safety guidelines

Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities


Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs
Medical Device | May 04, 2026

Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs

New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology


Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive
News | May 04, 2026

Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive

The initiative pairs consumer engagement with a public health message about prevention and early detection


Bristol Myers Squibb begins 2026 with growth momentum
News | May 04, 2026

Bristol Myers Squibb begins 2026 with growth momentum

The company’s Growth Portfolio delivered $6.2 billion in revenue


Dr Lal PathLabs posts strong Q4 FY26 results with 16.6% revenue growth & PAT at Rs. 132 Cr
News | May 02, 2026

Dr Lal PathLabs posts strong Q4 FY26 results with 16.6% revenue growth & PAT at Rs. 132 Cr

The company posted revenue of Rs. 703 crore in Q4 FY26


Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion


JP Nadda highlights India’s push for APIs, biologics and translational research
Policy | May 01, 2026

JP Nadda highlights India’s push for APIs, biologics and translational research

On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus


RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth
News | April 30, 2026

RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth

In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth